Free Trial

Orgenesis (ORGS) Insider Trading & Ownership

Orgenesis logo
$1.10 +0.01 (+0.92%)
(As of 11/21/2024 ET)

Orgenesis (NASDAQ:ORGS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.66%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$29,483.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get ORGS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Orgenesis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ORGS Insider Buying and Selling by Quarter

Orgenesis Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2024Jacob SafierMajor ShareholderBuy1,010$3.30$3,333.00  
1/30/2024Jacob SafierMajor ShareholderBuy2,500$3.30$8,250.00  
1/25/2024Jacob SafierMajor ShareholderBuy2,500$3.20$8,000.00  
1/22/2024Jacob SafierMajor ShareholderBuy1,000$2.90$2,900.00  
1/18/2024Jacob SafierMajor ShareholderBuy1,000$3.30$3,300.00  
1/10/2024Jacob SafierMajor ShareholderBuy1,000$3.70$3,700.00  
(Data available from 1/1/2013 forward)

ORGS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Orgenesis includes Jacob Safier. Learn more on insiders at ORGS.

5.66% of Orgenesis stock is owned by insiders. Learn more on ORGS's insider holdings.

The following insider purchased ORGS shares in the last 24 months: Jacob Safier ($29,483.00).

Insiders have purchased a total of 9,010 ORGS shares in the last 24 months for a total of $29,483.00 bought.

Orgenesis Key Executives

  • Ms. Vered Caplan M.Sc. (Age 55)
    Chairperson of the Board, CEO & President
    Compensation: $341.38k
  • Prof. Sarah Ferber Ph.D. (Age 70)
    Founder & Chief Scientific Officer
    Compensation: $268.32k
  • Mr. Victor Miller (Age 54)
    CFO, Secretary & Treasurer
  • Pierre Lammeretz
    Interim Chief Operating Officer
  • Dr. Shimon Hassin Ph.D.
    Chief Technology Officer
  • Mr. Evan Fishman
    Chief Financial Officer of Orgenesis Biotech
  • Mr. Joseph Carpinelli
    Chief Financial Officer of Octomera


This page (NASDAQ:ORGS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners